Literature DB >> 22188453

Targeting mitochondria in fighting cancer.

Vladimir Gogvadze1.   

Abstract

During the last years, there have been a number of reports that prove involvement of mitochondria in the pathogenesis of variety of disorders including cancer and neurodegenerative diseases. Alteration of vital mitochondrial functions - production of ATP, calcium buffering capacity, abnormal production of reactive oxygen species, can be potentially responsible for pathogenesis of cancer and neurodegenerative diseases. Involvement of mitochondria in various types of cell death makes them attractive targets for tumor cell elimination. This review describes the role of mitochondria in tumor cells and how targeting of mitochondria can be used as a tool in fighting cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188453     DOI: 10.2174/138161211798764933

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  19 in total

Review 1.  Mitochondrial ROS and cancer drug resistance: Implications for therapy.

Authors:  Imoh S Okon; Ming-Hui Zou
Journal:  Pharmacol Res       Date:  2015-08-11       Impact factor: 7.658

Review 2.  Restoration of mitochondria function as a target for cancer therapy.

Authors:  Tariq A Bhat; Sandeep Kumar; Ajay K Chaudhary; Neelu Yadav; Dhyan Chandra
Journal:  Drug Discov Today       Date:  2015-03-09       Impact factor: 7.851

3.  NEXT STEP IN DRUG DELIVERY: GETTING TO INDIVIDUAL ORGANELLES.

Authors:  Vladimir Torchilin
Journal:  Drug Deliv Transl Res       Date:  2012-10-11       Impact factor: 4.617

4.  Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression.

Authors:  Matthew R Hart; Hsin-Yuan Su; Derrick Broka; Aarthi Goverdhan; Joyce A Schroeder
Journal:  Mol Ther       Date:  2013-10-01       Impact factor: 11.454

5.  Mitochondria and familial predisposition to breast cancer.

Authors:  Stefania Weigl; Angelo Paradiso; Stefania Tommasi
Journal:  Curr Genomics       Date:  2013-05       Impact factor: 2.236

6.  Mechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cells.

Authors:  Yumna H Shabaik; Melissa Millard; Nouri Neamati
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

7.  Early effects of the antineoplastic agent salinomycin on mitochondrial function.

Authors:  A Managò; L Leanza; L Carraretto; N Sassi; S Grancara; R Quintana-Cabrera; V Trimarco; A Toninello; L Scorrano; L Trentin; G Semenzato; E Gulbins; M Zoratti; I Szabò
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

8.  Efficient photodynamic therapy on human retinoblastoma cell lines.

Authors:  Jan Walther; Stanislas Schastak; Sladjana Dukic-Stefanovic; Peter Wiedemann; Jochen Neuhaus; Thomas Claudepierre
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Astrocyte elevated gene-1 mediates glycolysis and tumorigenesis in colorectal carcinoma cells via AMPK signaling.

Authors:  Hong-tao Song; Yu Qin; Guo-dong Yao; Zhen-nan Tian; Song-bin Fu; Jing-shu Geng
Journal:  Mediators Inflamm       Date:  2014-04-16       Impact factor: 4.711

10.  Response to rotenone is glucose-sensitive in a model of human acute lymphoblastic leukemia: involvement of oxidative stress mechanism, DJ-1, Parkin, and PINK-1 proteins.

Authors:  Miguel Mendivil-Perez; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Oxid Med Cell Longev       Date:  2014-05-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.